Hacer B. Ozturk-Afacan

Etlik, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Clinicopathological features of adult lymphoblastic lymphoma: a retrospective multicenter study from Türkiye.

Clinicopathological features of adult lymphoblastic lymphoma: a retrospective multicenter study from Türkiye.

Journal: Frontiers in oncology

Published: March 01, 2026

Prognostic value of the CONUT score in newly diagnosed diffuse large B-cell lymphoma.

Prognostic value of the CONUT score in newly diagnosed diffuse large B-cell lymphoma.

Journal: Oncology letters

Published: December 15, 2025

Prognostic Impact of Serum Albumin Levels at Diagnosis in Patients with Chronic Lymphocytic Leukemia.

Prognostic Impact of Serum Albumin Levels at Diagnosis in Patients with Chronic Lymphocytic Leukemia.

Journal: Journal of clinical medicine

Published: December 11, 2025

Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry.

Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry.

Journal: Journal of clinical medicine

Published: September 07, 2025

Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients.

Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients.

Journal: Annals of hematology

Published: August 13, 2025

Clinical characteristics and outcomes in Epstein-Barr virus-positive diffuse large B-cell lymphoma: a multicenter retrospective study.

Clinical characteristics and outcomes in Epstein-Barr virus-positive diffuse large B-cell lymphoma: a multicenter retrospective study.

Journal: Turkish journal of medical sciences

Published: April 07, 2025

Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project.

Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project.

Journal: BMC cancer

Published: April 01, 2025

Potential effects of liver dysfunction at the time of diagnosis in patients with acute myeloid leukemia.

Potential effects of liver dysfunction at the time of diagnosis in patients with acute myeloid leukemia.

Journal: Experimental and therapeutic medicine

Published: July 18, 2024

Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study.

Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: January 13, 2023

Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.

Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: November 15, 2021

Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect.

Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect.

Journal: Journal of clinical pharmacy and therapeutics

Published: May 30, 2021

Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis.

Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis.

Journal: Leukemia & lymphoma

Published: May 20, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026